Progressive Care Website Logo.JPG
Progressive Care Inc. Announces Formation of RXMD Therapeutics Inc. Specializing in Cannabinoid-Based and Alternative Nutraceutical Products 
October 01, 2019 08:00 ET | Progressive Care, Inc.
MIAMI, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announces formation of its wholly owned subsidiary,...
Progressive Care Website Logo.JPG
Progressive Care Inc. Announces $3.7 Million Gross Revenue for August 2019
September 24, 2019 08:00 ET | Progressive Care, Inc.
MIAMI, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and...
Endonovo Therapeutics Announces Second Quarter Results
August 13, 2019 13:39 ET | Endonovo Therapeutics Inc.
LOS ANGELES, Aug. 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announces financial and operating results for the...
Endonovo Therapeutics Announces National Rollout of SofPulse® Post-Operative Opioid Alternative into Hospitals
June 13, 2019 08:30 ET | Endonovo Therapeutics Inc.
WOODLAND HILLS, Calif., June 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive...
Progressive Care Website Logo.JPG
Progressive Care Inc. Issues 1st Quarter 2019 Quarterly Report Conference Call Highlights
May 16, 2019 08:00 ET | Progressive Care, Inc.
MIAMI, May 16, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today issued 1st Quarter 2019 Quarterly Report Conference Call...
MilanaPharm logo
MilanaPharm Receives Notice of Allowance from U.S. Patent Office For Lidocaine Topical Formulation
May 09, 2019 10:11 ET | MilanaPharm
TALLASSEE, Ala., May 09, 2019 (GLOBE NEWSWIRE) -- MilanaPharm, a specialty pharmaceutical company focused on the development of innovative, non-opioid pharmaceutical solutions for wound management...
Bettys Eddies cherry beet fruit chew
MariMed Acquires Betty’s Eddies to Expand Precision Dosed Cannabis Product Lines
November 16, 2017 08:15 ET | MariMed Inc.
NEWTON, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- MariMed Inc., (OTCQB:MRMD) today announced it has acquired the rights to the intellectual property (IP), formulations, recipes, proprietary...